- A clinical trial of the Covaxin vaccine is going on in AIIMS on children. Registration has started from 28th May. 108 children have registered voluntarily. Out of this, clinical trials were conducted on 15 children and only three were found worthy of a trial.
The trial of the corona vaccine on children has started in the country. A clinical trial of indigenous vaccine Covaxin on children started on Tuesday at Patna AIIMS. Under this, three children have been given the first dose of the Covid vaccine. At present all three children are healthy. AIIMS has been given a target of trials on a total of 80 children.
Patna AIIMS’s Covid in-charge Dr. Sanjeev Kumar said on Wednesday that this test on children in the age group of 12 to 18 years started from June 1 i.e. Tuesday. On the first day of the trial on children of Covaxin, three children were given the first dose of the vaccine. All three are in the age group of 12 to 18 years and are residents of Patna. All three are healthy. No side effects have been observed on anyone. The hospital has given a diary to the parents of the three children and asked them to monitor their health. If children face any problem during this time, they have been asked to contact Patna AIIMS immediately.
108 children voluntarily registered
A clinical trial of the Covaxin vaccine is going on in AIIMS on children. Registration has started from 28th May. 108 children have registered voluntarily. Out of this, clinical trials were conducted on 15 children and only three were found worthy of a trial.
2nd dose after 28 days
These three children will be given the second dose of Covaxin after a gap of 28 days. Children will be thoroughly screened for any side effects of the vaccine once their vaccination is complete. Patna AIIMS has divided the children into three groups for the trial on the basis of their age. These three age groups are 2-5 years, 6-12 years, and 12-18 years.
Let us inform you that the Drug Controller General of India (DCGI) on May 11 had approved the clinical trial of Bharat Biotech-made Corona Vaccine Covaxin on children aged 2 to 18 years. Covaxin will conduct trials on 525 children aged 2 to 18 years.